Royce & Associates LP Acquires New Stake in Concentra Group Holdings Parent, Inc. (NYSE:CON)

Royce & Associates LP bought a new position in Concentra Group Holdings Parent, Inc. (NYSE:CON) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 296,536 shares of the company’s stock, valued at approximately $5,865,000. Royce & Associates LP owned approximately 0.23% of Concentra Group Holdings Parent at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Smartleaf Asset Management LLC bought a new stake in shares of Concentra Group Holdings Parent during the fourth quarter valued at approximately $25,000. Motco purchased a new stake in Concentra Group Holdings Parent during the 4th quarter valued at $32,000. Empowered Funds LLC bought a new stake in shares of Concentra Group Holdings Parent in the 4th quarter worth $49,000. Nisa Investment Advisors LLC bought a new stake in shares of Concentra Group Holdings Parent in the 4th quarter worth $59,000. Finally, GAMMA Investing LLC purchased a new position in shares of Concentra Group Holdings Parent in the fourth quarter worth $64,000.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CON. JPMorgan Chase & Co. lifted their price objective on Concentra Group Holdings Parent from $29.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday. Royal Bank of Canada reiterated an “outperform” rating and issued a $30.00 price target on shares of Concentra Group Holdings Parent in a research note on Thursday, January 23rd. Wells Fargo & Company decreased their price objective on shares of Concentra Group Holdings Parent from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, March 12th. Finally, Bank of America raised their target price on shares of Concentra Group Holdings Parent from $24.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, January 23rd. Eight research analysts have rated the stock with a buy rating, According to data from MarketBeat, Concentra Group Holdings Parent has an average rating of “Buy” and a consensus target price of $28.50.

Concentra Group Holdings Parent Stock Performance

Shares of NYSE CON opened at $21.03 on Thursday. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 5.20. Concentra Group Holdings Parent, Inc. has a 12-month low of $18.89 and a 12-month high of $24.81. The firm has a market capitalization of $2.68 billion and a price-to-earnings ratio of 13.92. The firm has a 50 day moving average of $22.29 and a 200 day moving average of $21.58.

Concentra Group Holdings Parent (NYSE:CON) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $465.00 million during the quarter, compared to analysts’ expectations of $465.00 million. On average, research analysts anticipate that Concentra Group Holdings Parent, Inc. will post 1.47 earnings per share for the current year.

Concentra Group Holdings Parent Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Tuesday, March 18th will be paid a dividend of $0.0625 per share. The ex-dividend date of this dividend is Tuesday, March 18th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.19%. Concentra Group Holdings Parent’s dividend payout ratio (DPR) is presently 16.56%.

About Concentra Group Holdings Parent

Concentra Group Holdings Parent, Inc provides occupational health services in the United States. The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics.